The Manitoba IBD Cohort Study: A prospective longitudinal evaluation of the use of complementary and alternative medicine services and products

Simple item page
dc.contributor.authorRawsthorne, Patricia
dc.contributor.authorClara, Ian
dc.contributor.authorGraff, Lesley A.
dc.contributor.authorWalker, John
dc.contributor.authorBernstein, Kylie
dc.contributor.authorCarr, Rachel
dc.contributor.authorEdiger, Jason
dc.contributor.authorRogala, Linda
dc.contributor.authorMiller, Norine
dc.contributor.authorBernstein, Charles N.
dc.date.accessioned2015-05-11T17:53:39Z
dc.date.available2015-05-11T17:53:39Z
dc.date.issued2012-04
dc.description.abstractOBJECTIVE: To determine the prevalence of complementary and alternative medicine (CAM) use over time in a population-based cohort of patients with inflammatory bowel disease (IBD). METHODS: The Manitoba IBD Cohort Study is a longitudinal, population-based study of multiple determinants of health outcomes in an IBD cohort. Participants completed semi-annual surveys, and annual in-person interviews. Enquiries about the use of 12 types of CAM service providers and 13 CAM products, based on items from a national survey, were included at months 0, 12, 30 and 54. RESULTS: Overall, 74% of respondents used a CAM service or product in the 4.5-year period, with approximately 40% using some type of CAM at each time point, and 14% using CAM consistently at every time point. There was a trend for women to use CAM more than men; there was no difference in CAM use between patients with Crohn's disease and those with ulcerative colitis. The most often used CAM services (on average) were massage therapy (30%) and chiropractic (14%), physiotherapy (4%), acupuncture (3.5%) and naturopathy/homeopathy (3.5%). A wide range of CAM products were used, with Lactobacillus acidophilus (8%), fish and other oils (5.5%), glucosamine (4%) and chamomile (3.5%) as the most common. On average, only 18% of consumers used CAM for their IBD, so the majority chose it for other problems. There were no differences in psychological variables between CAM users and non-users. CONCLUSIONS: Those with IBD commonly try CAM, although very few use these approaches regularly over the years. CAM is not usually used by patients with IBD for disease management, but clinicians should be aware that many will test the services and products.en_US
dc.identifier.citationGut. 2012 Apr;61(4):521-7en_US
dc.identifier.doi10.1136/gutjnl-2011-300219
dc.identifier.urihttp://hdl.handle.net/1993/30426
dc.language.isoengen_US
dc.publisherGuten_US
dc.relation.ispartofseries61(4);521-7
dc.rightsopen accessen_US
dc.subjectIBD Cohorten_US
dc.subjectInflammatory Bowel Diseaseen_US
dc.subjectalternative Medicineen_US
dc.subjectBernsteinen_US
dc.titleThe Manitoba IBD Cohort Study: A prospective longitudinal evaluation of the use of complementary and alternative medicine services and productsen_US
dc.typeArticleen_US
dc.typeDataseten_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Rawsthorne CAM Gut pdf of submitted paper.pdf
Size:
183.75 KB
Format:
Adobe Portable Document Format
Description:
Main Article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.27 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works